Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

Market Cap	20.74B
Revenue (ttm)	1.74B
Net Income (ttm)	163.85M
Shares Out	n/a
EPS (ttm)	0.28
PE Ratio	126.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Dec 5, 2024

Volume	259,825
Open	34.80
Previous Close	34.73
Day's Range	34.65 - 35.45
52-Week Range	21.36 - 35.76
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About ASX: FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,031
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In 2023, FPH's revenue was 1.74 billion, an increase of 10.23% compared to the previous year's 1.58 billion. Earnings were 132.60 million, a decrease of -47.02%.

Financial numbers in NZD